How can ketamine support patients with Complex Regional Pain Syndrome (CRPS)?
Complex Regional Pain Syndrome (CRPS) is one of the most challenging chronic pain conditions clinicians encounter. Characterized by severe, disproportionate pain and nervous system dysregulation, CRPS often persists despite medications, physical therapy, nerve blocks, and surgical interventions.
In carefully selected patients with CRPS who have not responded to conventional treatments, physician-guided ketamine therapy may help reduce pain intensity, improve functional capacity, and support participation in broader multidisciplinary care. It is not curative and typically requires ongoing evaluation and maintenance.
For some patients, ketamine becomes part of the conversation only after years of unsuccessful treatment attempts. Understanding how it fits into real clinical courses can help referring providers evaluate appropriateness and set realistic expectations.
Why CRPS Is Particularly Difficult to Treat
CRPS involves more than localized injury or inflammation. Over time, abnormal signaling within the central nervous system amplifies pain perception, often resulting in severe sensory, autonomic, and functional changes.
Patients may experience:
- Persistent, disproportionate pain
- Hypersensitivity to touch or movement
- Autonomic changes such as swelling or temperature variation
- Significant functional limitation
- Mood and sleep disruption related to chronic suffering
As these symptoms persist, pain becomes increasingly resistant to standard therapies alone.
Where Ketamine Fits in CRPS Care
Ketamine is evaluated in CRPS primarily for its effects on central pain processing.
By modulating NMDA receptor activity—receptors involved in amplifying pain signals within the brain and spinal cord—ketamine may help reduce abnormal pain amplification that contributes to central sensitization. In select patients, this can translate into periods of lower pain intensity and improved functional capacity.
Ketamine is not a first-line therapy for CRPS. It is considered only after conservative and interventional options have been exhausted and when pain significantly interferes with daily life.
What Real-World Outcomes Can Look Like
Clinical response to ketamine varies, and no two patients follow the same course. However, real patient experiences help illustrate how ketamine may function within a broader care plan.For some patients, long-standing CRPS has resulted in years of escalating interventions with limited benefit.
Missy, a 48-year-old female patient, with upper-extremity CRPS following an injury, experienced severe, unrelenting pain that persisted even after major surgical intervention. Ketamine therapy did not eliminate the diagnosis, but it provided consistent periods of relief that allowed her to resume daily activities, manage mood symptoms associated with chronic pain, and maintain stability through regular maintenance treatments.
Barry, a 70-year-old male patient, developed CRPS following surgery and spent over a year pursuing injections, nerve blocks, medications, and physical therapy with minimal improvement. After initiating ketamine therapy, he experienced predictable reductions in pain that allowed him to return to activities that had become impossible, including caring for grandchildren, traveling, and coaching youth sports. Importantly, ketamine enabled participation in complementary practices such as mindfulness-based approaches and movement therapies, which further supported long-term management.
In both cases, ketamine functioned as a tool, not a cure—providing windows of reduced pain that supported function, planning, and engagement with life.
What Ketamine Does and Does Not Change
Ketamine does not reverse CRPS or eliminate breakthrough pain entirely. Patients may still experience symptom flares, particularly as the effects of treatment diminish.
What ketamine may offer is:
- Reduced pain intensity during periods of effect
- Greater predictability in symptom patterns
- Improved tolerance for physical and behavioral therapies
- Reduced secondary distress associated with severe pain
Clear expectation-setting is essential. Patients benefit most when ketamine is framed as one component of a comprehensive, ongoing care strategy.
The Role of Maintenance and Individualization
CRPS rarely responds to a single intervention. For patients who benefit from ketamine, ongoing maintenance at individualized intervals is often necessary.
Treatment plans are adjusted based on patient response, side effects, functional goals, and coordination with existing providers. Consistency and follow-up play a central role in maintaining benefit.
Why Coordination with Referring Providers Matters
CRPS management requires long-term collaboration.
At Vitalitas, ketamine therapy is delivered with a strong emphasis on communication with referring providers. Follow-up summaries outline treatment course, response, and ongoing plans so that ketamine therapy can be integrated into the patient’s broader care framework.
This coordination supports continuity, realistic goal-setting, and shared clinical responsibility.
Key Takeaways for Referring Providers
- CRPS is a complex condition involving central nervous system dysregulation
- Ketamine is considered only after other treatments have failed
- Outcomes vary and require careful expectation-setting
- Ketamine supports function and engagement rather than curing disease
- Ongoing maintenance and coordination are central to success
For providers caring for patients with treatment-resistant chronic pain, clinical discussion can support informed referral decisions. A brief consultation with Dr. Eve Langston is available to review appropriateness and care coordination.
Patients in the Denver metro area are welcome to contact our team with questions or to support coordination with their existing care providers.
